ANDEHIGH SIGNALFINANCIAL10-K

ANDE experienced a dramatic decline in cash position alongside significantly reduced operating cash flow generation, signaling potential liquidity stress.

The company's cash and equivalents fell precipitously from $561.8M to $98.3M, representing an 82.5% decline that suggests either major capital deployment, debt repayment, or operational cash burn. Combined with meaningfully reduced operating cash flow and substantially higher capital expenditures, this indicates the company may be in an intensive investment phase or facing working capital pressures that require close monitoring.

Comparing 2026-02-18 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

ANDE's financial profile shows clear signs of cash consumption stress, with operating cash flow declining meaningfully while capital expenditures grew substantially to $233.1M. The dramatic reduction in cash reserves coupled with lower net income and reduced current assets suggests the company deployed significant resources during the period, either for strategic investments or to address operational challenges. This cash burn pattern, if sustained, could pressure future financial flexibility and warrants careful attention to liquidity management.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-82.5%
$561.8M$98.3M

Cash declined 82.5% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Capital Expenditure
Cash Flow
+56.3%
$149.2M$233.1M

Capital expenditure jumped 56.3% — major investment cycle underway; assess returns on deployment.

Operating Cash Flow
Cash Flow
-46.6%
$331.5M$177.0M

Operating cash flow fell 46.6% — earnings quality concerns; investigate working capital changes and non-cash items.

R&D Expense
P&L
+25%
$800K$1.0M

R&D investment increased 25% — signals commitment to future product development, though near-term margin impact.

Current Assets
Balance Sheet
-16.6%
$2.9B$2.4B

Current assets declined 16.6% — monitor working capital adequacy and short-term liquidity.

Net Income
P&L
-16.1%
$114.0M$95.7M

Net income declined 16.1% — review whether driven by operations, interest costs, or non-recurring items.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-19
ADDED
The registrant had 33,880,130 common shares outstanding, no par value, at February 6, 2026.
Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 7A.
Forward-looking statements may appear throughout this report, including the following sections: Business (Part I, Item 1 of this Form 10-K), Risk Factors (Part I, Item 1A of this Form 10-K), and Management s Discussion and Analysis of Financial Condition and Results of Operations (Part II, Item 7 of this Form 10-K).
These forward-looking statements generally are identified by terminology such as may , anticipates , believes , estimates , predicts , and the negative of these terms or other comparable terminology and similar expressions.
(the "Company") is a leading, nimble North American agriculture and renewable fuels company.
+7 more — sign up free →
REMOVED
The registrant had 34,028,010 common shares outstanding, no par value, at February 7, 2025.
Management's Discussion and Analysis of Financial Condition and Results of Operations 18 Item 7A.
(the "Company") is a diversified company rooted in agriculture.
Founded in Maumee, Ohio in 1947, the Company is a significant player in the North American agricultural supply chain and conducts its business in the trade, renewables, and nutrient industrial sectors.
Segment Descriptions The Company's operations are classified into three reportable business segments: Trade, Renewables, and Nutrient Industrial.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →